Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01214044 · ClinicalTrials.gov registry record · NA
Circadian Effects of Escitalopram
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01214044 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 19 participants.
The verdict
NCT01214044, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The goal of the study is to obtain preliminary data that will test whether the antidepressant medication escitalopram resets the body clock: a collection of nerve cells in the brain that control the timing of many body processes. The study will also test whether the improvement in depression symptoms with escitalopram correlates with the degree to which the timing of the body clock is properly aligned with the timing of sleep.
Interventions
- DRUG placebo/escitalopram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2008-05 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01214044
The ClinicalTrials.gov registry entry for NCT01214044 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which placebo/escitalopram is the first listed.
NCT01214044 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01214044 about?
NCT01214044 is a clinical study titled "Circadian Effects of Escitalopram". The goal of the study is to obtain preliminary data that will test whether the antidepressant medication escitalopram resets the body clock: a collection of nerve cells in the brain that control the timing of many body processes. The study will also test whether the improvement in depression symptom...
What is the current status of trial NCT01214044?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2008-05. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01214044?
The interventions under investigation include: placebo/escitalopram (DRUG).
Who is sponsoring clinical trial NCT01214044?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.